PubMed:10358028
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-135 | Sentence | denotes | 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor. |
| T2 | 136-356 | Sentence | denotes | 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) plays a major role in the stimulation of bone growth, mineralization, and intestinal calcium and phosphate absorption; it also acts as a general inhibitor of cellular proliferation. |
| T3 | 357-534 | Sentence | denotes | Several new, clinically relevant compounds dissociate antiproliferative and calcemic activities of 1,25(OH)2D3, but the molecular basis for this has not been clearly elucidated. |
| T4 | 535-723 | Sentence | denotes | Here, we tested whether the potency of one class of compounds, 20-epi analogues, to induce myeloid cell differentiation, is because of direct molecular effects on vitamin D receptor (VDR). |
| T5 | 724-953 | Sentence | denotes | We report that two 20-epi analogues, MC1627 and MC1288, induced differentiation and transcription of p21(Waf1,Cip1), a key VDR target gene involved in growth inhibition, at a concentration 100-fold lower than that of 1,25(OH)2D3. |
| T6 | 954-1100 | Sentence | denotes | We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex. |
| T7 | 1101-1374 | Sentence | denotes | Compared with the interaction of VDR with RXR or GRIP-1, the differentiation dose-response most closely correlated to the ligand-dependent recruitment of the DRIP coactivator complex to VDR and to the ability of the receptor to activate transcription in a cell-free system. |
| T8 | 1375-1581 | Sentence | denotes | These results provide compelling links between the efficiency of the 20-epi analogue in inducing VDR/DRIP interactions, transactivation in vitro, and its enhanced ability to induce cellular differentiation. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 216-220 | http://purl.obolibrary.org/obo/MAT_0000299 | denotes | bone |
| T2 | 249-259 | http://purl.obolibrary.org/obo/MAT_0000043 | denotes | intestinal |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 75-99 | protein | denotes | DRIP coactivator complex |
| T2 | 115-134 | protein | denotes | vitamin D3 receptor |
| T3 | 698-716 | protein | denotes | vitamin D receptor |
| T4 | 718-721 | protein | denotes | VDR |
| T5 | 825-828 | DNA | denotes | p21 |
| T6 | 829-833 | DNA | denotes | Waf1 |
| T7 | 834-838 | DNA | denotes | Cip1 |
| T8 | 847-862 | DNA | denotes | VDR target gene |
| T9 | 1006-1009 | protein | denotes | VDR |
| T10 | 1032-1035 | protein | denotes | RXR |
| T11 | 1037-1043 | protein | denotes | GRIP-1 |
| T12 | 1049-1056 | protein | denotes | DRIP205 |
| T13 | 1075-1099 | protein | denotes | DRIP coactivator complex |
| T14 | 1134-1137 | protein | denotes | VDR |
| T15 | 1143-1146 | protein | denotes | RXR |
| T16 | 1150-1156 | protein | denotes | GRIP-1 |
| T17 | 1259-1283 | protein | denotes | DRIP coactivator complex |
| T18 | 1287-1290 | protein | denotes | VDR |
| T19 | 1472-1475 | protein | denotes | VDR |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-135 | Sentence | denotes | 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor. |
| S2 | 136-356 | Sentence | denotes | 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) plays a major role in the stimulation of bone growth, mineralization, and intestinal calcium and phosphate absorption; it also acts as a general inhibitor of cellular proliferation. |
| S3 | 357-534 | Sentence | denotes | Several new, clinically relevant compounds dissociate antiproliferative and calcemic activities of 1,25(OH)2D3, but the molecular basis for this has not been clearly elucidated. |
| S4 | 535-723 | Sentence | denotes | Here, we tested whether the potency of one class of compounds, 20-epi analogues, to induce myeloid cell differentiation, is because of direct molecular effects on vitamin D receptor (VDR). |
| S5 | 724-953 | Sentence | denotes | We report that two 20-epi analogues, MC1627 and MC1288, induced differentiation and transcription of p21(Waf1,Cip1), a key VDR target gene involved in growth inhibition, at a concentration 100-fold lower than that of 1,25(OH)2D3. |
| S6 | 954-1100 | Sentence | denotes | We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex. |
| S7 | 1101-1374 | Sentence | denotes | Compared with the interaction of VDR with RXR or GRIP-1, the differentiation dose-response most closely correlated to the ligand-dependent recruitment of the DRIP coactivator complex to VDR and to the ability of the receptor to activate transcription in a cell-free system. |
| S8 | 1375-1581 | Sentence | denotes | These results provide compelling links between the efficiency of the 20-epi analogue in inducing VDR/DRIP interactions, transactivation in vitro, and its enhanced ability to induce cellular differentiation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 20-44 | NP | denotes | 1,25-dihydroxyvitamin D3 |
| C2 | 111-134 | NP | denotes | the vitamin D3 receptor |
| C3 | 136-174 | NP | denotes | 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) |
| C4 | 294-296 | NP | denotes | it |
| C5 | 456-467 | NP | denotes | 1,25(OH)2D3 |
| C6 | 574-596 | NP | denotes | one class of compounds |
| C7 | 598-614 | NP | denotes | 20-epi analogues |
| C8 | 698-722 | NP | denotes | vitamin D receptor (VDR) |
| C9 | 739-759 | NP | denotes | two 20-epi analogues |
| C10 | 761-778 | NP | denotes | MC1627 and MC1288 |
| C11 | 825-839 | NP | denotes | p21(Waf1,Cip1) |
| C12 | 841-892 | NP | denotes | a key VDR target gene involved in growth inhibition |
| C13 | 941-952 | NP | denotes | 1,25(OH)2D3 |
| C14 | 1006-1030 | NP | denotes | VDR interacting proteins |
| C16 | 1032-1035 | NP | denotes | RXR |
| C17 | 1037-1043 | NP | denotes | GRIP-1 |
| C18 | 1049-1056 | NP | denotes | DRIP205 |
| C20 | 1071-1099 | NP | denotes | the DRIP coactivator complex |
| C19 | 1058-1099 | NP | denotes | a subunit of the DRIP coactivator complex |
| C15 | 1032-1099 | NP | denotes | RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex |
| C21 | 1134-1137 | NP | denotes | VDR |
| C22 | 1143-1146 | NP | denotes | RXR |
| C23 | 1150-1156 | NP | denotes | GRIP-1 |
| C24 | 1255-1283 | NP | denotes | the DRIP coactivator complex |
| C25 | 1287-1290 | NP | denotes | VDR |
| C26 | 1313-1325 | NP | denotes | the receptor |
| C27 | 1440-1459 | NP | denotes | the 20-epi analogue |
| C28 | 1525-1528 | NP | denotes | its |
| R1 | C3 | C1 | coref-ident | "1,25-Dihydroxyvitamin D3 (1,25(OH)2D3)","1,25-dihydroxyvitamin D3" |
| R2 | C4 | C3 | coref-pron | it,"1,25-Dihydroxyvitamin D3 (1,25(OH)2D3)" |
| R3 | C5 | C3 | coref-ident | "1,25(OH)2D3","1,25-Dihydroxyvitamin D3 (1,25(OH)2D3)" |
| R4 | C7 | C6 | coref-appos | 20-epi analogues,one class of compounds |
| R5 | C8 | C2 | coref-ident | vitamin D receptor (VDR),the vitamin D3 receptor |
| R6 | C10 | C9 | coref-appos | MC1627 and MC1288,two 20-epi analogues |
| R7 | C12 | C11 | coref-appos | a key VDR target gene involved in growth inhibition,"p21(Waf1,Cip1)" |
| R8 | C13 | C5 | coref-ident | "1,25(OH)2D3","1,25(OH)2D3" |
| R9 | C19 | C18 | coref-appos | a subunit of the DRIP coactivator complex,DRIP205 |
| R10 | C15 | C14 | coref-appos | "RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex",VDR interacting proteins |
| R11 | C21 | C8 | coref-ident | VDR,vitamin D receptor (VDR) |
| R12 | C22 | C16 | coref-ident | RXR,RXR |
| R13 | C23 | C17 | coref-ident | GRIP-1,GRIP-1 |
| R14 | C24 | C20 | coref-ident | the DRIP coactivator complex,the DRIP coactivator complex |
| R15 | C25 | C21 | coref-ident | VDR,VDR |
| R16 | C26 | C25 | coref-ident | the receptor,VDR |
| R17 | C28 | C27 | coref-pron | its,the 20-epi analogue |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-16 | other_organic_compound | denotes | 20-Epi analogues |
| T2 | 20-44 | lipid | denotes | 1,25-dihydroxyvitamin D3 |
| T3 | 75-99 | protein_complex | denotes | DRIP coactivator complex |
| T4 | 115-134 | protein_family_or_group | denotes | vitamin D3 receptor |
| T5 | 136-160 | lipid | denotes | 1,25-Dihydroxyvitamin D3 |
| T6 | 162-173 | lipid | denotes | 1,25(OH)2D3 |
| T7 | 216-227 | other_name | denotes | bone growth |
| T8 | 229-243 | other_name | denotes | mineralization |
| T9 | 333-355 | other_name | denotes | cellular proliferation |
| T10 | 433-452 | other_name | denotes | calcemic activities |
| T11 | 456-467 | lipid | denotes | 1,25(OH)2D3 |
| T12 | 598-614 | other_organic_compound | denotes | 20-epi analogues |
| T13 | 698-716 | protein_family_or_group | denotes | vitamin D receptor |
| T14 | 718-721 | protein_family_or_group | denotes | VDR |
| T15 | 743-759 | other_organic_compound | denotes | 20-epi analogues |
| T16 | 761-767 | other_organic_compound | denotes | MC1627 |
| T17 | 772-778 | other_organic_compound | denotes | MC1288 |
| T18 | 825-828 | DNA_domain_or_region | denotes | p21 |
| T19 | 829-833 | DNA_domain_or_region | denotes | Waf1 |
| T20 | 834-838 | DNA_domain_or_region | denotes | Cip1 |
| T21 | 847-850 | protein_family_or_group | denotes | VDR |
| T22 | 941-952 | lipid | denotes | 1,25(OH)2D3 |
| T23 | 1006-1009 | protein_family_or_group | denotes | VDR |
| T24 | 1032-1035 | protein_molecule | denotes | RXR |
| T25 | 1037-1043 | protein_molecule | denotes | GRIP-1 |
| T26 | 1049-1056 | protein_molecule | denotes | DRIP205 |
| T27 | 1075-1099 | protein_complex | denotes | DRIP coactivator complex |
| T28 | 1134-1137 | protein_family_or_group | denotes | VDR |
| T29 | 1143-1146 | protein_molecule | denotes | RXR |
| T30 | 1150-1156 | protein_molecule | denotes | GRIP-1 |
| T31 | 1162-1191 | other_name | denotes | differentiation dose-response |
| T32 | 1223-1251 | other_name | denotes | ligand-dependent recruitment |
| T33 | 1259-1283 | protein_complex | denotes | DRIP coactivator complex |
| T34 | 1287-1290 | protein_family_or_group | denotes | VDR |
| T35 | 1357-1373 | other_name | denotes | cell-free system |
| T36 | 1444-1459 | other_organic_compound | denotes | 20-epi analogue |
| T37 | 1472-1475 | protein_family_or_group | denotes | VDR |
| T38 | 1556-1580 | other_name | denotes | cellular differentiation |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 863-881 | HP_0001507 | denotes | involved in growth |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 216-220 | Body_part | denotes | bone | http://purl.obolibrary.org/obo/MAT_0000299 |
| T2 | 249-259 | Body_part | denotes | intestinal | http://purl.obolibrary.org/obo/MAT_0000043 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 216-220 | Body_part | denotes | bone | http://purl.obolibrary.org/obo/UBERON_0001474|http://purl.obolibrary.org/obo/UBERON_0002481 |
| T3 | 626-638 | Body_part | denotes | myeloid cell | http://purl.obolibrary.org/obo/CL_0000763 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 626-638 | Cell | denotes | myeloid cell | http://purl.obolibrary.org/obo/CL:0000763 |